| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $899.9M | +16.8% |
| Cost of Revenue | $725.0M | +20.1% |
| R&D Expense | $65.3M | -1.3% |
| SG&A Expense | $106.7M | -8.0% |
| Operating Income | $2.9M | -81.0% |
| Pre-tax Income | -$10.7M | -186.0% |
| Income Tax | $3.4M | -62.8% |
| Net Income | -$14.1M | -512.7% |
| EPS (Basic) | -$0.52 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.8M | -35.9% |
| Accounts Receivable | $158.2M | +5.2% |
| Inventory | $152.6M | +10.5% |
| Current Assets | $409.6M | -0.3% |
| Total Assets | $652.1M | -2.0% |
| Current Liabilities | $177.7M | +2.7% |
| Long-term Debt | $169.3M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.8M | +118.8% |
| Capital Expenditures | $27.2M | +18.7% |
| Investing Cash Flow | -$28.6M | -201.9% |
| Financing Cash Flow | -$7.3M | -131.9% |
| Free Cash Flow | -$20.4M | +65.5% |
| -500.0% |
| EPS (Diluted) | -$0.52 | -533.3% |
| Stockholders' Equity |
| $280.9M |
| -5.1% |